Sign In
Buy CNS
$80.79
-1.71 (-2.07%)
At Close: Jul 21, 2026
Vistagen to Participate in Stifel 2025 Virtual CNS Forum
08:30am, Tuesday, 04'th Mar 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize
Cohen & Steers Launches SICAV Short Duration Preferred Income Fund
04:00am, Monday, 03'rd Mar 2025
LONDON , March 3, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today the launch of the Cohen & Steers SICAV Short Duration Preferred Income Fund. This is the firm's second fund foc
31 Upcoming Dividend Increases, Including 3 Kings
09:16pm, Thursday, 27'th Feb 2025
This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strate
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
06:34pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dis
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
06:28pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
06:20pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sou
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
06:19pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of th
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
05:43pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of
CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
09:05am, Wednesday, 26'th Feb 2025
Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopha
Corero Network Security Strengthens Latin America Presence with Key Win and Growing Partner Network
07:00am, Tuesday, 25'th Feb 2025
MARLBOROUGH, Mass. , Feb. 25, 2025 /PRNewswire/ -- As part of its strategic expansion in Latin America, Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) pro
Cohen & Steers, Inc. Declares Quarterly Dividend
04:23pm, Thursday, 20'th Feb 2025
NEW YORK , Feb. 20, 2025 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the first quarter of 2025 in the amount of $0.62 per share of common s
CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
09:00am, Thursday, 20'th Feb 2025
Webcast presentation Wednesday, February 26th at 3:20 PM CET HOUSTON, TX / ACCESS Newswire / February 20, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical c
Trumpflation Positions Cohen & Steers Poorly Due To Real Estate And Preferred Focus
05:50pm, Wednesday, 19'th Feb 2025
Cohen & Steers (CNS) faces AUM declines due to asset depreciation in REITs and preferred shares amid persistent inflation affecting bond markets. This could be a portent for incoming outflows or inflo
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
09:00am, Wednesday, 19'th Feb 2025
On-demand video webcast now available here HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializin
CNS Pharmaceuticals Announces Reverse Stock Split
08:30am, Wednesday, 19'th Feb 2025
HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments fo
